OTC : LABFF

Laboratorios Farmaceuticos Rovi, S.A. — Earnings Estimates

$90.61 USD

$0 (0.0%)

Volume
100
Average Volume
89
Market Capitalization
$4.63B
P/E Ratio
26.88
Dividend Yield
1.66%
Price Target
Year High
$90.61
Year Low
$90.61
Day High
—
Day Low
—
Payout Ratio
$0.26
Current Ratio
$2.05

Annual earnings financials

LABFF financial data with annual/quarterly toggle

LABFF GAAP EPS - Annual & Quarterly

LABFF Sales Revenue - Annual & Quarterly

LABFF Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

LABFF Estimated and Actual Revenue by Quarter
LABFF Estimated and Actual EPS by Quarter
LABFF Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-06-30 4 49.77M 53.44M 51.95M 45.14M 48.46M 47.11M
2026-03-31 2 45.41M 45.92M 45.67M 41.18M 41.64M 41.41M
2025-12-31 7 60.99M 62.41M 61.53M 55.31M 56.59M 55.8M
2025-09-30 3 61.74M 62.63M 62.04M 55.99M 56.79M 56.26M
2025-06-30 1 46.91M 46.91M 46.91M 42.53M 42.53M 42.53M
2025-03-31 4 43.51M 44.57M 44.28M 39.45M 40.41M 40.15M
LABFF Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-06-30 4 - - - 34.3M 36.83M 35.8M
2026-03-31 2 - - - 31.29M 31.64M 31.47M
2025-12-31 7 - - - 42.03M 43M 42.4M
2025-09-30 3 - - - 42.54M 43.16M 42.75M
2025-06-30 1 - - - 32.32M 32.32M 32.32M
2025-03-31 4 - - - 29.98M 30.71M 30.51M
LABFF Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-06-30 4 168.8M 181.25M 176.18M 0 0 0 0
2026-03-31 2 154M 155.73M 154.87M 0 0 0 0
2025-12-31 7 206.86M 211.65M 208.68M 0 0 0 0
2025-09-30 3 209.39M 212.4M 210.39M 0 0 0 0
2025-06-30 1 159.08M 159.08M 159.08M 0 0 0 0
2025-03-31 4 147.55M 151.15M 150.17M 0 0 0 0